<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have studied a new high-affinity competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi>, D-CPP-ene (SDZ-EAA 494), in two models of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the cat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model (6 hours' survival), pretreatment with D-CPP-ene reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size by 64% (15 mg/kg dose) and 60% (4.5 mg/kg dose) </plain></SENT>
<SENT sid="2" pm="."><plain>There was no reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> size at a dose of 1.5 mg/kg </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment 1 hour after the occlusion reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size slightly, but not significantly </plain></SENT>
<SENT sid="4" pm="."><plain>In a new model of <z:hpo ids='HP_0100309'>subdural hematoma</z:hpo> in the rat, the zone of cortical ischemic damage beneath the blood clot was reduced by 54% with D-CPP-ene pretreatment </plain></SENT>
<SENT sid="5" pm="."><plain>Neuroprotective efficacy in a gyrencephalic species comparable to that of noncompetitive <z:chebi fb="68" ids="48706">antagonists</z:chebi> thus can be achieved with this agent </plain></SENT>
<SENT sid="6" pm="."><plain>These experiments also indicate that competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> may be clinically useful after traumatic intracranial <z:mp ids='MP_0008817'>hematomas</z:mp> </plain></SENT>
</text></document>